google-site-verification: googlec7193c3de77668c9.html

CDC pauses release of COVID vaccine effectiveness study

[

CDC pauses release of COVID vaccine effectiveness study

A health report on COVID-19 vaccines has been delayed after concerns about how the study was conducted.

The report, from the U.S. Centers for Disease Control and Prevention (CDC), found that COVID vaccines reduced emergency room visits and hospital stays last winter.

But release of the report was postponed by Dr. Jay Bhattacharya, who was serving as the agency’s acting director at the time.

A report summary obtained by The New York Times indicated that the study showed that vaccination:

  • Reduced emergency visits by 50%
  • Reduced hospitalizations by 55%

“Dr. Bhattacharya expressed concerns about the observational method used in this study to calculate vaccine effectiveness, and the scientific team is working to address these concerns,” Andrew Nixon, a spokesman for the U.S. Department of Health and Human Services (HHS), told The Times in an email.

He said the review was routine.

“Dr. Bhattacharya wants to make sure that the paper uses the most appropriate methodology for such a study,” Nixon said.

The findings were slated for publication March 19 in the CDC’s Morbidity and Mortality Weekly Report (MMWR).

A few experts said the delay is unusual.

“A political appointee at CDC would very rarely be involved in a review or decision regarding MMWR,” Dr. Debra Houry told The Times. She served as the CDC’s chief medical officer before resigning in August.

“Previously, this would have been reviewed by a career scientist who worked across administrations,” she added.

Amid ongoing health threats like measles, staffing shortages and Bhattacharaya heading up the National Institutes of Health, this would be even more unusual, Houry said.

Observational studies are commonly used to measure vaccine effectiveness.

Bhattacharya has suggested using randomized clinical trials instead, where some participants receive the vaccine and others receive a placebo.

However, experts say those trials are often expensive and difficult to conduct quickly.

More information

The U.S. Centers for Disease Control and Prevention has more on vaccine effectiveness.

© 2026 HealthDay. All rights reserved.

Advertisements

Citation:
CDC pauses release of COVID vaccine effectiveness study (2026, April 10)
retrieved 10 April 2026
from https://medicalxpress.com/news/2026-04-cdc-covid-vaccine-effectiveness.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

See also  Low levels of a single enzyme influence pathway to malignancy in colorectal cancer, scientists find

Check Also

Preoperative chemo and immunotherapy combo shrinks head, neck cancer tumors

[ Combining chemotherapy with immunotherapy before surgery for head and neck cancer is associated with …

Drugs developed in China reaching international markets, research finds

[ Credit: Unsplash/CC0 Public Domain China has become an increasingly important contributor to pharmaceutical development, …

Why memories get fuzzier with age—and what replaces them

[ Credit: Pixabay/CC0 Public Domain Research from the University of East Anglia shows how our …

Leave a Reply

Available for Amazon Prime